[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $imrx $IMRX stock sees increased attention with insider buys and institutional interest, but sentiment remains low. Wall Street eyes the stock as revenue more than doubles YoY. ### About $imrx Social media analysis of the stock ticker $IMRX, likely representing a biotechnology or pharmaceutical company. ### Insights [#](/topic/$imrx/insights) - $imrx posts created is up XXXXX% from the previous week. ### Engagements: XXXXX [#](/topic/$imrx/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$imrx/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXXX -XX% **1-Year High**: XXXXXX on 2025-06-18 **1-Year Low**: XXX on 2025-10-05 | Social Network | X | YouTube | | -------------- | - | ------- | | Engagements | XXXXX | X | ### Mentions: XX [#](/topic/$imrx/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$imrx/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XXX **1-Year High**: XXXXX on 2025-07-09 **1-Year Low**: X on 2025-04-27 | Social Network | X | YouTube | | -------------- | - | ------- | | Mentions | XX | X | ### Creators: XX [#](/topic/$imrx/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$imrx/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $imrx in the last XX hours which is up XX% from XX in the previous XX hours **Daily Average**: XX **1-Year High**: XXXXX on 2025-07-08 **1-Year Low**: X on 2025-04-27 The most influential creators that mention $imrx in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@SkipperDoodle3](/creator/twitter/SkipperDoodle3) | X | XXX | X | XXX | | [@Quantumup1](/creator/twitter/Quantumup1) | X | XXXXX | X | XXX | | [@DalvinVarnado](/creator/twitter/DalvinVarnado) | X | XXXXXX | X | XXX | | [@BioValues](/creator/twitter/BioValues) | X | XXXXX | X | XX | | [@Elisabe66802172](/creator/twitter/Elisabe66802172) | X | XXX | X | XX | [View More](/list/creators/$imrx/100) ### Sentiment: XX% [#](/topic/$imrx/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$imrx/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XXX% no change **1 Month**: XX% +16% **1-Year High**: XXX% on 2025-04-27 **1-Year Low**: XX% on 2025-09-18 **Most Supportive Themes** - **Positive Valuation and Pipeline Advancements:** (40%) Posts highlight the undervaluation of $IMRX, citing strong revenue growth and advancements in its pipeline, particularly in oncology. - **Insider Activity and Institutional Interest:** (30%) Mentions of insider buys and institutional investments, such as Fidelity and HBM Healthcare, suggest confidence in the company's future. **Most Critical Themes** - **Unclear if the company is a good investment:** (10%) Some posts question the company's decisions and the rationale behind certain financial moves, such as the fundraising from SNY. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXX | XX% | XXX | XX% | XX | X% | | YouTube | X | X% | X | X% | X | X% | | | | | | | | | | Total | XXXXX | XX% | XXX | XX% | XX | X% | **Top assets mentioned** In the posts about $imrx in the last XX hours [Sanofi (SNY)](/topic/sanofi) [Synthetify (SNY)](/topic/$sny) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [uniQure N.V. (QURE)](/topic/$qure) [Pfizer, Inc. (PFE)](/topic/$pfe) [Home Depot, Inc. (HD)](/topic/$hd) [Ethereum (ETH)](/topic/ethereum) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) **Top topics mentioned** In the posts about $imrx in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [sanofi](/topic/sanofi), [$sny](/topic/$sny), [stocks](/topic/stocks), [$bbio](/topic/$bbio), [$pmnt](/topic/$pmnt), [$stkh](/topic/$stkh), [$iobt](/topic/$iobt), [$pgen](/topic/$pgen), [$tnon](/topic/$tnon), [$aptc](/topic/$aptc), [$vmar](/topic/$vmar), [$imrxs](/topic/$imrxs), [insider](/topic/insider), [upside](/topic/upside), [$25m](/topic/$25m), [$omic](/topic/$omic), [$bcab](/topic/$bcab), [$artv](/topic/$artv), [$qure](/topic/$qure), [$118k](/topic/$118k), [$tgen](/topic/$tgen), [$pfe](/topic/$pfe), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$hd](/topic/$hd), [$fubo](/topic/$fubo), [stocks technology](/topic/stocks-technology), [$sprb](/topic/$sprb), [wall street](/topic/wall-street), [ethereum](/topic/ethereum), [coins layer 1](/topic/coins-layer-1), [$rvmd](/topic/$rvmd), [phd](/topic/phd), [momentum](/topic/momentum), [$200m](/topic/$200m), [$mtnb](/topic/$mtnb), [$pepg](/topic/$pepg), [$lxeo](/topic/$lxeo), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$regn](/topic/$regn), [investment](/topic/investment), [$1s](/topic/$1s), [$ifrx](/topic/$ifrx), [$vsee](/topic/$vsee), [$whwk](/topic/$whwk), [$buru](/topic/$buru), [$abve](/topic/$abve), [$rvmds](/topic/$rvmds), [$72keeps](/topic/$72keeps), [$zlab](/topic/$zlab), [$78reitd](/topic/$78reitd), [$qtih](/topic/$qtih), [$wstl](/topic/$wstl), [nasdaq](/topic/nasdaq), [$625m](/topic/$625m), [$nvo](/topic/$nvo), [$mrk](/topic/$mrk), [stocks communication services](/topic/stocks-communication-services), [make a](/topic/make-a), [$ryde](/topic/$ryde), [$nwgl](/topic/$nwgl), [$kwe](/topic/$kwe), [$ptle](/topic/$ptle), [$apvo](/topic/$apvo), [$qnrx](/topic/$qnrx), [$asmb](/topic/$asmb), [$rani](/topic/$rani), [$49m](/topic/$49m), [$20m](/topic/$20m), [market cap](/topic/market-cap), [$95m](/topic/$95m), [25m](/topic/25m), [$kb](/topic/$kb), [$ldi](/topic/$ldi), [$uwmc](/topic/$uwmc), [$sei](/topic/$sei), [$open](/topic/$open), [$axsm](/topic/$axsm), [$nvct](/topic/$nvct), [bulls](/topic/bulls), [positions](/topic/positions), [$lqda](/topic/$lqda), [vids](/topic/vids), [stocks financial services](/topic/stocks-financial-services), [subscription](/topic/subscription), [usdt](/topic/usdt), [$dgnx](/topic/$dgnx), [$gnty](/topic/$gnty), [$coop](/topic/$coop), [coins algorand](/topic/coins-algorand), [$mrkr](/topic/$mrkr), [$prok](/topic/$prok), [primary market](/topic/primary-market), [$syn](/topic/$syn), [coins defi](/topic/coins-defi), [coins bsc](/topic/coins-bsc), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$prvb](/topic/$prvb), [$10s](/topic/$10s), [frog](/topic/frog) ### Top Social Posts [#](/topic/$imrx/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Wall Street Eyes Are on $IMRX Revenue more than doubled YoY; pipeline spans IMM-1-104 and IMM-6-415 with multiple readouts ahead. Narrowing burn rate supports progress. Full breakdown in our" [X Link](https://x.com/carroll_jody/status/1979954574292292078) [@carroll_jody](/creator/x/carroll_jody) 2025-10-19T16:55Z XXX followers, XX engagements "Wall Street traders wont tell you this $IMRX raised $25M via direct offering to advance Phase 1/2 trials in KRAS-driven cancers. Cash runway now extended into 2026. Group guiding this stock full details" [X Link](https://x.com/ShigematsuHeidi/status/1979954439898439909) [@ShigematsuHeidi](/creator/x/ShigematsuHeidi) 2025-10-19T16:54Z XXX followers, XX engagements "$IMRX Valuation Is Completely Undervalued Immuneering (IMRX) posted FY24 revenue of $4.9M (+140% YoY) vs $2.0M last year. Market cap near $95M with PS 19x undervalued vs oncology biotech peers advancing pipelines. Group has locked this stock entry price inside" [X Link](https://x.com/babiru36/status/1979954362131853525) [@babiru36](/creator/x/babiru36) 2025-10-19T16:54Z 1961 followers, XX engagements "(2) "The Field" does offer some clarity on these moves from $QURE $QNRX $ASMB $RANI and even $SPRB. The valuations are now absurd with nothing behind it. The mkt maintains contrarian running what has no business running. And dogging the only one that should be XXX% higher IMRX" [X Link](https://x.com/SkipperDoodle3/status/1979953964117319834) [@SkipperDoodle3](/creator/x/SkipperDoodle3) 2025-10-19T16:53Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$IMRX stock sees increased attention with insider buys and institutional interest, but sentiment remains low. Wall Street eyes the stock as revenue more than doubles YoY.
Social media analysis of the stock ticker $IMRX, likely representing a biotechnology or pharmaceutical company.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-06-18
1-Year Low: XXX on 2025-10-05
Social Network | X | YouTube |
---|---|---|
Engagements | XXXXX | X |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1-Year High: XXXXX on 2025-07-09
1-Year Low: X on 2025-04-27
Social Network | X | YouTube |
---|---|---|
Mentions | XX | X |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $imrx in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1-Year High: XXXXX on 2025-07-08
1-Year Low: X on 2025-04-27
The most influential creators that mention $imrx in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@SkipperDoodle3 | X | XXX | X | XXX |
@Quantumup1 | X | XXXXX | X | XXX |
@DalvinVarnado | X | XXXXXX | X | XXX |
@BioValues | X | XXXXX | X | XX |
@Elisabe66802172 | X | XXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% +16%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-18
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXX | XX% | XX | X% |
YouTube | X | X% | X | X% | X | X% |
Total | XXXXX | XX% | XXX | XX% | XX | X% |
Top assets mentioned In the posts about $imrx in the last XX hours
Sanofi (SNY) Synthetify (SNY) BridgeBio Pharma, Inc. Common Stock (BBIO) uniQure N.V. (QURE) Pfizer, Inc. (PFE) Home Depot, Inc. (HD) Ethereum (ETH) Revolution Medicines, Inc. Common Stock (RVMD) Regeneron Pharmaceuticals Inc (REGN) Regeneron Pharmaceuticals Inc (REGN)
Top topics mentioned In the posts about $imrx in the last XX hours
stocks healthcare, sanofi, $sny, stocks, $bbio, $pmnt, $stkh, $iobt, $pgen, $tnon, $aptc, $vmar, $imrxs, insider, upside, $25m, $omic, $bcab, $artv, $qure, $118k, $tgen, $pfe, stocks consumer cyclical, $hd, $fubo, stocks technology, $sprb, wall street, ethereum, coins layer 1, $rvmd, phd, momentum, $200m, $mtnb, $pepg, $lxeo, regeneron pharmaceuticals inc, $regn, investment, $1s, $ifrx, $vsee, $whwk, $buru, $abve, $rvmds, $72keeps, $zlab, $78reitd, $qtih, $wstl, nasdaq, $625m, $nvo, $mrk, stocks communication services, make a, $ryde, $nwgl, $kwe, $ptle, $apvo, $qnrx, $asmb, $rani, $49m, $20m, market cap, $95m, 25m, $kb, $ldi, $uwmc, $sei, $open, $axsm, $nvct, bulls, positions, $lqda, vids, stocks financial services, subscription, usdt, $dgnx, $gnty, $coop, coins algorand, $mrkr, $prok, primary market, $syn, coins defi, coins bsc, coins solana ecosystem, $prvb, $10s, frog
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Wall Street Eyes Are on $IMRX Revenue more than doubled YoY; pipeline spans IMM-1-104 and IMM-6-415 with multiple readouts ahead. Narrowing burn rate supports progress. Full breakdown in our"
X Link @carroll_jody 2025-10-19T16:55Z XXX followers, XX engagements
"Wall Street traders wont tell you this $IMRX raised $25M via direct offering to advance Phase 1/2 trials in KRAS-driven cancers. Cash runway now extended into 2026. Group guiding this stock full details"
X Link @ShigematsuHeidi 2025-10-19T16:54Z XXX followers, XX engagements
"$IMRX Valuation Is Completely Undervalued Immuneering (IMRX) posted FY24 revenue of $4.9M (+140% YoY) vs $2.0M last year. Market cap near $95M with PS 19x undervalued vs oncology biotech peers advancing pipelines. Group has locked this stock entry price inside"
X Link @babiru36 2025-10-19T16:54Z 1961 followers, XX engagements
"(2) "The Field" does offer some clarity on these moves from $QURE $QNRX $ASMB $RANI and even $SPRB. The valuations are now absurd with nothing behind it. The mkt maintains contrarian running what has no business running. And dogging the only one that should be XXX% higher IMRX"
X Link @SkipperDoodle3 2025-10-19T16:53Z XXX followers, XXX engagements
/topic/$imrx